NBY News and Press, NovaBay Pharmaceuticals Inc. From 11/01/21

Private Placement to fund acquisition of DERMAdoctor NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a Securities Purchase Agreement with certain institutional investors in c...

NovaBay Pharmaceuticals, Inc. (NBY) DERMAdoctor Acquisition Conference Call September 29, 2021, 04:30 PM ET Company Participants Jody Cain - SVP, LHA, IR Justin Hall - CEO Audrey Kunin - DERMAdoctor, Co-Founder and Chief Product Officer Jeffrey Kunin - DERMAdoctor President, CEO and Co-Founde...

The following slide deck was published by NovaBay Pharmaceuticals, Inc. in conjunction with this event. For further details see: NovaBay DERMAdoctor Transaction Call

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call and webcast with accompanying slide presentation today, Wednesday, September 29, 2021 beginning at 4:30 p.m....

3 Penny Stocks to Add to Your Watchlist in October 2021 Right now, there is major movement among both penny stocks and blue chips. And, with so many catalysts contributing to the volatility in the stock market, how can we as investors stay ahead? Well, the best way to do so is to stay a...

Acquisition has the potential to double topline revenue in 2022 Operational synergies and diversified product portfolio expected to drive profitability Conference Call Wednesday at 1:30 p.m. Pacific time NovaBay ® Pharmaceuticals, Inc . (NYSE America...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that management will present at the H.C. Wainwright 23 rd Annual Global Investment Conference being held September 13-15, 2021. The company presentation will be posted to the “ Events ” pa...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces an agreement with Okra Limited to distribute their Zocular dry eye products alongside Avenova in NovaBay’s physician-...

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2021 Earnings Conference Call August 12, 2021, 04:30 PM ET Company Participants Jody Cain - IR-LHA Justin Hall - CEO and General Counsel Andy Jones - CFO Conference Call Participants Presentation Operator Good day, and welcome to the NovaBay Pharmaceutic...

Fourth consecutive quarter of record Avenova ® OTC unit sales with record OTC revenue of $1.3 million Avenova availability expands to more than half of all CVS stores across the U.S. ImprimisRx begins promoting prescription Avenova to eyecare professionals n...